You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 7,258,999

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,258,999

Title:	PTH responsive gene
Abstract:	This invention relates to a novel PTH gene. The invention further relates to methods of screening, diagnosis and development of therapies for bone related disorders.
Inventor(s):	Robinson; John Allen (Downingtown, PA), Stojanovic-Susulic; Vedrana (Princeton Junction, NJ), Babij; Philip (Dunstable, MA), Murrills; Richard John (Yardley, PA)
Assignee:	Wyeth (Madison, NJ)
Application Number:	10/705,716
Patent Claims:	1. An isolated polypeptide encoded by an isolated nucleic acid fragment selected from the group consisting of: (a) an isolated nucleic acid fragment encoding SEQ ID NO: 2; (b) an isolated nucleic acid fragment encoding an amino acid sequence having at least 98% identity with SEQ ID NO: 2; and (c) an isolated nucleic acid fragment that hybridizes with the isolated nucleic acid fragment of (a) under hybridization conditions of 6.times.SSC (1M NaCl), 45 to 50% formamide, 1% SDS at 37.degree. C., and a wash in 0.5.times. to 1.times.SSC at 55 to 60.degree. C.; wherein said polypeptide is parathyroid hormone anabolic induced gene in bone (PAIGB) polypeptide and has osteoblast bone forming activity in bone tissues. 2. The isolated polypeptide of claim 1 having the amino acid sequence set forth in SEQ ID NO: 2. 3. The isolated polypeptide of claim 1 which is involved in parathyroid hormone signaling pathway. 4. The isolated polypeptide of claim 1 which when overexpressed induces bone forming activity in bone tissues. 5. The isolated polypeptide of claim 1 which is overexpressed in response to intermittent parathyroid hormone administration. 6. A composition for regulating bone-forming activity in a mammal comprising an isolated polypeptide of claim 1. 7. A composition according to claim 6, wherein said parathyroid hormone anabolic induced gene in bone polypeptide is from human osteoblast cells. 8. A composition according to claim 6, wherein the bone forming activity is the regulation of bone growth. 9. A composition according to claim 6, wherein the bone forming activity is the regulation of bone density. 10. The composition according to claim 6, wherein the parathyroid hormone anabolic induced gene is bone polypeptide has the amino acid sequence set forth in SEQ ID NO: 2.

Details for Patent 7,258,999

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015	⤷ Try a Trial	2022-11-12
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.